Trade CSTL stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Castle Biosciences, Inc. (CSTL) is trading at US$35.34, down 3.92% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$1.04B. Over the past 52 weeks, CSTL has traded between US$17.72 and US$44.28. On Syfe you can trade CSTL with $0 commission and add it to your watchlist.
| Previous close | US$36.78 |
|---|---|
| Market cap | US$1.04B |
| 52-week range | US$17.72 – US$44.28 |
| Volume | 530.19K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Castle Biosciences, Inc.
Castle Biosciences, Inc. is a molecular diagnostics company, which offers innovative test solutions to aid clinicians in the diagnosis and treatment of dermatologic cancers, barrett’s esophagus, uveal melanoma, and in the treatment of mental health conditions. The firm offers DecisionDx-Melanoma, a proprietary multi-gene expression profile (GEP) test that predicts the risk of metastasis and recurrence for patients diagnosed with invasive cutaneous melanoma. It also markets DecisionDx-UM, Decision Dx DiffDx-Melanoma, DecisonDx-CMSeq, DecisionDx-SCC, DecsionDx-UMSeq, and DecisonDX-PRAME. The company was founded by Derek J. Maetzold in September 2007 and is headquartered in Friendswood, TX.
Year: 2019
Castle Biosciences Gets Approval for Dual Listing on Nasdaq Texas
Aug 17, 11:38 AM · MT Newswires
-- Earnings Flash (CSTL) Castle Biosciences Posts Q2 Revenue of $103.5 Million, vs. FactSet Est of $86.2 Million
Jul 30, 9:46 PM · MT Newswires
-- Earnings Flash (CSTL) Castle Biosciences Posts Q2 Adjusted EPS -$0.07, vs. FactSet Est of -$0.41
Jul 30, 9:45 PM · MT Newswires
Castle Biosciences Gets New York State Department of Health Approval of AdvanceAD-Tx Test
Jul 14, 8:59 PM · MT Newswires
Castle Biosciences, Inc. (CSTL) stock is trading at US$35.34, -3.92% from the previous close of US$36.78.
The market cap for Castle Biosciences, Inc. (CSTL) stock is approximately US$1.04B.
The 52-week high for Castle Biosciences, Inc. (CSTL) stock is US$44.28.
The 52-week low for Castle Biosciences, Inc. (CSTL) stock is US$17.72.
Castle Biosciences, Inc. (CSTL) does not currently pay a dividend.
Stay on top of CSTL
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
